|
Chronic Pain Modulation of Mesolimbic Dopamine Signaling for Natural and Opiate Rewards |
1F31DA056200-01 |
|
NIDA |
2022 |
|
Neurocognitive Impairments Resulting from Adolescent Prescription Opioid Use Disorder: Longitudinal Impact, Neural Mechanisms, and Comorbidities |
1K99DA056288-01 |
|
NIDA |
2022 |
|
Mechanisms of prenatal opioid exposure on brain and behavior |
1R01DA050871-01A1 |
|
NIDA |
2022 |
|
Role of disability and pain in opioid overdose: mechanism and risk mitigation |
1R01DA053243-01A1 |
|
NIDA |
2022 |
|
Neurocognitive implications of cannabidiol (CBD) while aging with HIV |
1R03DA057146-01 |
|
NIDA |
2022 |
|
Social determinants of substance use disorder treatment outcomes in a vulnerable population |
1R21DA055229-01 |
|
NIDA |
2022 |
|
Psychostimulants, Attention Deficit and Basal Ganglia Disorders |
1R21DA055980-01 |
|
NIDA |
2022 |
|
Dissecting functional roles of MeCP2 condensates in neurons with chemogenetic tools |
1R21DA056293-01 |
|
NIDA |
2022 |
|
Neural circuitry mediating behavioral flexibility |
3R00DA042934-05S2 |
|
NIDA |
2022 |
|
Leveraging ΔFosB as a potential therapeutic for Alzheimers Disease |
3R01DA040621-07S1 |
|
NIDA |
2022 |